查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1652018

CRISPR·Cas遺傳基因的全球市場:市場規模·佔有率·趨勢，產業分析 (各類型·各用途·各終端用戶·各地區)，未來預測 (2025年～2034年)

CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report: By Type, Application, End User, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，全球 CRISPR/Cas 基因市場預計到 2034 年將達到 228.2 億美元。該報告提供了有關當前市場動態的詳細見解，並對未來市場的成長進行了分析。

CRISPR 和 Cas 基因市場包括將 CRISPR 和 Cas 技術用於醫學、農業和生物技術領域的基因編輯應用。該技術可以精確修改 DNA，從而推動基因研究、疾病治療和作物改良的進步。由於其具有徹底改變個人化醫療、基因治療和農業實踐的潛力，該市場正在快速成長。關鍵推動因素包括對基因研究的投資增加、對基因治療的需求不斷增長以及對更永續的農業解決方案的需求。然而，道德問題和監管障礙可能會阻礙市場擴張。

基因編輯技術的進步、基因研究投入的增加以及醫療保健、農業和生物技術領域的應用不斷擴大，推動了 CRISPR 和 Cas 基因市場的需求不斷增長。關鍵推動因素包括基於 CRISPR 的療法治療遺傳疾病的潛力、對具有改良性狀的轉基因作物日益增長的需求、以及對高效藥物發現工具日益增長的需求。 CRISPR-Cas基因的市場機會在於個人化醫療的開發、罕見疾病的基因治療以及將CRISPR融入農業生物技術以實現永續糧食生產。主要趨勢包括向下一代 CRISPR 技術的轉變、基因治療臨床試驗的增加以及生物技術公司和學術機構之間更強的研究合作。

CRISPR/Cas 基因市場：概論

該產品領域佔據了最大的市場佔有率，這得益於對基因編輯研究和應用的 CRISPR 工具、試劑和試劑盒的高需求。由於將 CRISPR 相關研究和開發外包給合約研究組織 (CRO)，服務領域正在經歷最高的成長。

由於 CRISPR 在針對遺傳疾病、癌症和個人化醫療的基因治療中的應用越來越多，生物醫學領域在市場中佔據主導地位。農業領域是成長最快的領域，因為 CRISPR 技術被用於改良作物特性和提高糧食安全。

生物技術和製藥公司佔最大佔有率，對基於 CRISPR 的遺傳疾病治療方法和藥物研發進行了大量投資。 CRO 和 CDMO 領域成長最快，因為這些組織在為生技公司提供臨床試驗和基因編輯服務方面發揮關鍵作用。

北美憑藉強大的生物技術產業、大量研發投入以及對基因編輯技術的監管支持佔據市場主導地位。亞太地區是成長最快的地區，中國和印度等國家正迅速採用 CRISPR 技術。

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 CRISPR·Cas遺傳基因市場洞察

  • 市場概述
  • CRISPR·Cas遺傳基因的市場動態
    • 促進因素和機會
      • 基於 CRISPR 的治療最終使用者的進步 CRISPR 在農業生物應用的應用日益廣泛
    • 阻礙因素和課題
      • 分銷課題
  • 大環境分析
  • CRISPR·Cas遺傳基因市場趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球CRISPR·Cas遺傳基因市場:各類型

  • 主要的分析結果
  • 簡介
  • 產品
  • 服務

第6章 全球CRISPR·Cas遺傳基因市場:各用途

  • 主要的分析結果
  • 簡介
  • 生物醫學
  • 農業

第7章 全球CRISPR·Cas遺傳基因市場:各終端用戶

  • 主要的分析結果
  • 簡介
  • 生物科技·製藥企業
  • 學術機構·政府調查機關
  • CRO·CDMO

第8章 全球CRISPR·Cas遺傳基因市場:各地區

  • 主要的分析結果
  • 簡介
    • CRISPR·Cas遺傳基因市場評估:各地區 (2020～2034年)
  • 北美
    • 北美:各類型 (2020～2034年)
    • 北美:各用途 (2020～2034年)
    • 北美:各終端用戶 (2020～2034年)
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各類型 (2020～2034年)
    • 歐洲:各用途 (2020～2034年)
    • 歐洲:各終端用戶 (2020～2034年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各類型 (2020～2034年)
    • 亞太地區:各用途 (2020～2034年)
    • 亞太地區:各終端用戶 (2020～2034年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各類型 (2020～2034年)
    • 中東·非洲:各用途 (2020～2034年)
    • 中東·非洲:各終端用戶 (2020～2034年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各類型 (2020～2034年)
    • 南美:各用途 (2020～2034年)
    • 南美:各終端用戶 (2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 事業擴大·企業收購的分析
    • 事業擴大
    • 企業收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • CRISPR Therapeutics
  • Editas Medicine
  • Intellia Therapeutics
  • Caribou Biosciences
  • Sangamo Therapeutics
  • Agilent Technologies
  • Addgene
  • Thermo Fisher Scientific
  • Illumina
  • Life Technologies
  • Precision Biosciences
  • Beam Therapeutics
  • Cellectis
  • Gene Editing Technologies
  • Horizon Discovery
Product Code: PM1738

The global CRISPR & Cas genes market size is expected to reach USD 22.82 billion by 2034, according to a new study by Polaris Market Research. The report "CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report: By Type (Products and Services), Application (Biomedical and Agricultural), End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The CRISPR & Cas genes market involves the use of CRISPR-Cas technology for gene editing applications in medicine, agriculture, and biotechnology. This technology allows precise modifications to DNA, enabling advancements in genetic research, disease treatment, and crop improvement. The market is experiencing rapid growth due to its potential to revolutionize personalized medicine, gene therapies, and agricultural practices. Key drivers include increasing investment in genetic research, rising demand for gene therapies, and the need for more sustainable agricultural solutions. However, ethical concerns and regulatory hurdles may affect market expansion.

The rising CRISPR & Cas genes market demand is attributed to advancements in gene-editing technologies, increased investments in genetic research, and expanding applications in healthcare, agriculture, and biotechnology. Key drivers include the potential for CRISPR-based therapies to treat genetic disorders, the growing demand for genetically modified crops with enhanced traits, and the rising need for efficient drug discovery tools. CRISPR & Cas genes market opportunities lie in the development of personalized medicine, gene therapies for rare diseases, and CRISPR's integration into agricultural biotechnology for sustainable food production. Major trends include the shift toward next-generation CRISPR technologies, an increase in clinical trials for gene therapies, and expanding research collaborations between biotech firms and academic institutions.

CRISPR & Cas Genes Market Report Highlights

The products segment holds the largest market share, driven by high demand for CRISPR tools, reagents, and kits for gene-editing research and applications. The services segment is experiencing the highest growth, fueled by increasing outsourcing of CRISPR-related research and development to contract research organizations (CROs).

The biomedical segment dominates the market, driven by the increasing use of CRISPR for gene therapies targeting genetic disorders, cancer, and personalized medicine. The agricultural segment is the fastest-growing, as CRISPR technologies are being leveraged to enhance crop traits and improve food security.

Biotechnology & pharmaceutical companies hold the largest share, investing heavily in CRISPR-based therapies for genetic diseases and drug discovery. The CRO and CDMO segment is growing the fastest, as these organizations play a critical role in advancing clinical trials and gene-editing services for biotech firms.

North America dominates the market, driven by a strong biotechnology sector, significant R&D investments, and regulatory support for gene-editing technologies. Asia-Pacific is the highest-growing region, with rapid adoption of CRISPR technologies in countries like China and India, focusing on both healthcare and agricultural applications.

Polaris Market Research has segmented the CRISPR & Cas Genes market report on the basis of type, application, end user, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

  • Products
  • Services

By Application Outlook (Revenue - USD Billion, 2020-2034)

  • Biomedical
  • Agricultural

By End User Outlook (Revenue - USD Billion, 2020-2034)

  • Biotechnology & Pharmaceutical Companies
  • Academics & Government Research Institutes
  • Contract Research Organizations (CRO) & CDMOs

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global CRISPR & Cas Genes Market Insights

  • 4.1. CRISPR & Cas Genes Market - Market Snapshot
  • 4.2. CRISPR & Cas Genes Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in CRISPR-Based Therapeutic End Users
      • 4.2.1.2. Increasing Use of CRISPR in Agricultural BioApplication
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Delivery challenges
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. CRISPR & Cas Genes Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global CRISPR & Cas Genes Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Product
    • 5.3.1. Global CRISPR & Cas Genes Market, by Product, by Region, 2020-2034 (USD Billion)
  • 5.4. Services
    • 5.4.1. Global CRISPR & Cas Genes Market, by Services, by Region, 2020-2034 (USD Billion)

6. Global CRISPR & Cas Genes Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Biomedical
    • 6.3.1. Global CRISPR & Cas Genes Market, by Biomedical, by Region, 2020-2034 (USD Billion)
  • 6.4. Agricultural
    • 6.4.1. Global CRISPR & Cas Genes Market, by Agricultural, by Region, 2020-2034 (USD Billion)

7. Global CRISPR & Cas Genes Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 7.3. Biotechnology & Pharmaceutical Companies
    • 7.3.1. Global CRISPR & Cas Genes Market, by Biotechnology & Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
  • 7.4. Academics & Government Research Institutes
    • 7.4.1. Global CRISPR & Cas Genes Market, by Academics & Government Research Institutes, by Region, 2020-2034 (USD Billion)
  • 7.5. Contract Research Organizations (CRO) & CDMOs
    • 7.5.1. Global CRISPR & Cas Genes Market, by Contract Research Organizations (CRO) & CDMOs, by Region, 2020-2034 (USD Billion)

8. Global CRISPR & Cas Genes Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. CRISPR & Cas Genes Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. CRISPR & Cas Genes Market - North America
    • 8.3.1. North America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.3.4. CRISPR & Cas Genes Market - U.S.
      • 8.3.4.1. U.S.: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.3.5. CRISPR & Cas Genes Market - Canada
      • 8.3.5.1. Canada: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 8.4. CRISPR & Cas Genes Market - Europe
    • 8.4.1. Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.4. CRISPR & Cas Genes Market - UK
      • 8.4.4.1. UK: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.5. CRISPR & Cas Genes Market - France
      • 8.4.5.1. France: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.6. CRISPR & Cas Genes Market - Germany
      • 8.4.6.1. Germany: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.7. CRISPR & Cas Genes Market - Italy
      • 8.4.7.1. Italy: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.8. CRISPR & Cas Genes Market - Spain
      • 8.4.8.1. Spain: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.9. CRISPR & Cas Genes Market - Netherlands
      • 8.4.9.1. Netherlands: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.10. CRISPR & Cas Genes Market - Russia
      • 8.4.10.1. Russia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.11. CRISPR & Cas Genes Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 8.5. CRISPR & Cas Genes Market - Asia Pacific
    • 8.5.1. Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.4. CRISPR & Cas Genes Market - China
      • 8.5.4.1. China: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.5. CRISPR & Cas Genes Market - India
      • 8.5.5.1. India: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.6. CRISPR & Cas Genes Market - Malaysia
      • 8.5.6.1. Malaysia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.7. CRISPR & Cas Genes Market - Japan
      • 8.5.7.1. Japan: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.8. CRISPR & Cas Genes Market - Indonesia
      • 8.5.8.1. Indonesia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.9. CRISPR & Cas Genes Market - South Korea
      • 8.5.9.1. South Korea: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.10. CRISPR & Cas Genes Market - Australia
      • 8.5.10.1. Australia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.11. CRISPR & Cas Genes Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 8.6. CRISPR & Cas Genes Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.4. CRISPR & Cas Genes Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.5. CRISPR & Cas Genes Market - UAE
      • 8.6.5.1. UAE: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.6. CRISPR & Cas Genes Market - Israel
      • 8.6.6.1. Israel: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.7. CRISPR & Cas Genes Market - South Africa
      • 8.6.7.1. South Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.8. CRISPR & Cas Genes Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 8.7. CRISPR & Cas Genes Market - Latin America
    • 8.7.1. Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.7.4. CRISPR & Cas Genes Market - Mexico
      • 8.7.4.1. Mexico: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.7.5. CRISPR & Cas Genes Market - Brazil
      • 8.7.5.1. Brazil: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.7.6. CRISPR & Cas Genes Market - Argentina
      • 8.7.6.1. Argentina: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.7.7. CRISPR & Cas Genes Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. CRISPR Therapeutics
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Editas Medicine
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Intellia Therapeutics
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Caribou Biosciences
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Sangamo Therapeutics
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Agilent Technologies
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Addgene
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Thermo Fisher Scientific
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Illumina
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Life Technologies
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Precision Biosciences
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Beam Therapeutics
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Cellectis
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Gene Editing Technologies
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Horizon Discovery
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables:

  • Table 1 Global CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 4 North America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 7 U.S.: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 10 Canada: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 13 Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 16 UK: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 19 France: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 22 Germany: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 25 Italy: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 28 Spain: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 31 Netherlands: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 34 Russia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 43 China: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 46 India: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 49 Malaysia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 52 Japan: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 55 Indonesia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 58 South Korea: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 61 Australia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 73 UAE: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 76 Israel: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 79 South Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 85 Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 88 Mexico: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 91 Brazil: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 94 Argentina: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global CRISPR & Cas Genes Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global CRISPR & Cas Genes Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global CRISPR & Cas Genes Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End User
  • Figure 11. Global CRISPR & Cas Genes Market, by End User, 2024 & 2034 (USD Billion)